ALS reports cyber security incident impacting operations

ALS discloses a cyber security breach affecting operations; most systems are restored as investigations continue.

The ALS Ltd (ASX: ALQ) share price is in focus today after the company reported a recent cyber security incident that temporarily disrupted some of its global operations.

Cybersecurity professional man inspects server room and works on iPad.

Image source: Getty Images

What did ALS report?

  • Identified malicious cyber activity with unauthorised third-party access to certain IT systems
  • Temporary disruption occurred in parts of operations, but vast majority now operational
  • Containment and remediation underway with the support of external cyber response experts
  • Australian Cyber Security Centre and other relevant bodies notified
  • Investigation ongoing to determine extent and impact on data

What else do investors need to know?

ALS moved quickly after detecting the breach, working alongside external cyber security specialists to minimise risk and restore services. The company says most operations are now back online, with targeted efforts continuing where needed.

Continuous updates will be provided for clients, government agencies, and stakeholders as the investigation unfolds. ALS is cooperating fully with authorities and remains committed to transparency throughout the process.

What's next for ALS?

ALS says it is focused on fully understanding the incident's impact and strengthening its cyber defences. The company is working towards comprehensive remediation in affected areas and will keep stakeholders informed as efforts progress.

Ongoing investment in IT security and incident response protocols remains a priority to protect client and company data. Investors can expect further updates as more details emerge from the investigation.

ALS share price snapshot

Over the past 12 months, ALS shares have risen 25%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 7% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

Two scientists analysing results on a computer screen.
Healthcare Shares

$10,000 invested in Pro Medicus and CSL shares 3 years ago is now worth…

Was I better off investing $10,000 into Pro Medicus or CSL shares three years ago?

Read more »

A share market investment manager monitors share price movements on his mobile phone and laptop
Healthcare Shares

Fund managers are loading up on CSL shares. Here's why

CSL is attracting renewed interest from fundies.

Read more »

Happy businessman fist pumping while looking at a tablet.
Healthcare Shares

Mesoblast wins FDA nod for new Ryoncil potency test

Mesoblast gets FDA approval for a new Ryoncil potency assay, aiming to ensure quality and support product expansion.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces.
Healthcare Shares

Can CSL shares hit $200? 3 things that need to go right

CSL needs to prove its earnings engine is accelerating again, not merely stabilising.

Read more »

Group of doctors celebrate by pumping fists in the air.
Healthcare Shares

Telix Pharmaceuticals vs Ramsay Healthcare: Which ASX healthcare stock made investors richer in 2026?

And find out which has the strongest upside ahead.

Read more »

Buy and sell written on red dice on top of stock market charts.
Broker Notes

Up 98%: Are CSL shares now a buy, hold or sell?

A leading expert provides his forecast for CSL’s rocketing shares.

Read more »

Doctor with stethoscope using a tablet in a hospital.
Broker Notes

What is this broker's view on Telix shares after yesterday's crash?

Here is the latest outlook from Bell Potter.

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

How much could the CSL share price rise in the next year?

Can CSL continue delivering very healthy returns?

Read more »